Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Samimi

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
The British Journal of Dermatology|July 7, 2020
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testingL Le Cleach, L Dousset, H Assier, et al.
The British Journal of Dermatology|September 28, 2021
Adcitmer<sup>®</sup> , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinomaC Esnault, V Leblond, C Martin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 29, 2021
Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of DermatologyR Guelimi, R Salle, L Dousset, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 26, 2020
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task ForceC Garbe, K Peris, E Soura, et al.
Annales De Dermatologie Et De Venereologie|February 7, 2024
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concernsM Amini-Adle, J-P Arnault, F Aubin, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
The British Journal of Dermatology|July 7, 2020
Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testingL Le Cleach, L Dousset, H Assier, et al.
The British Journal of Dermatology|September 28, 2021
Adcitmer<sup>®</sup> , a new CD56-targeting monomethyl auristatin E-conjugated antibody, is a potential therapeutic approach in Merkel cell carcinomaC Esnault, V Leblond, C Martin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 29, 2021
Non-acral skin manifestations during the COVID-19 epidemic: COVIDSKIN study by the French Society of DermatologyR Guelimi, R Salle, L Dousset, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 26, 2020
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task ForceC Garbe, K Peris, E Soura, et al.
Annales De Dermatologie Et De Venereologie|February 7, 2024
The combination of ipilimumab and nivolumab is still not reimbursed for BRAF-mutated melanoma patients in France: An unacceptable medical situation that raises ethical concernsM Amini-Adle, J-P Arnault, F Aubin, et al.
Pageof 8